-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMS-001 in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMS-001 in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMS-001 in Secondary Progressive Multiple Sclerosis (SPMS) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMS-001 in Primary Progressive Multiple Sclerosis (PPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMS-001 in Primary Progressive Multiple Sclerosis (PPMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMS-001 in Primary Progressive Multiple Sclerosis (PPMS) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-101 in Autoimmune Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-101 in Autoimmune Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-101 in Autoimmune Disorders Drug Details: IM-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-101 in Age Related Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-101 in Age Related Macular Degeneration report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-101 in Age Related Macular Degeneration Drug Details: IM-101...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-101 in Myasthenia Gravis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-101 in Myasthenia Gravis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-101 in Myasthenia Gravis Drug Details: IM-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IM-101 in Paroxysmal Nocturnal Hemoglobinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IM-101 in Paroxysmal Nocturnal Hemoglobinuria report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IM-101 in Paroxysmal Nocturnal Hemoglobinuria Drug Details: IM-101 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CYB-004 in Generalized Anxiety Disorder (GAD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CYB-004 in Generalized Anxiety Disorder (GAD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CYB-004 in Generalized Anxiety Disorder (GAD) Drug Details: CYB-004...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CYB-004 in Social Anxiety Disorder (SAD/Social Phobia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CYB-004 in Social Anxiety Disorder (SAD/Social Phobia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CYB-004 in Social Anxiety Disorder (SAD/Social Phobia) Drug...
-
Company Insights
NewBioretec Ltd Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Bioretec Ltd Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Bioretec Ltd (Bioretec), formerly BCI Bioabsorbable Concepts Oy is a medical device company that develops, manufactures and distributes bioabsorbable, bioactive, and drug releasing surgical implants. The company’s products include activa IM nail, activanail, activapin, activascrew, activascrew cannulated , activascrew interference, activascrew interference TCP, remeos screw. Its activascrew is designed to restore the original load carrying capacity of the bone. Bioretec...
-
Product Insights
Innovations in IM Nails – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in IM Nails - Global Pipeline Summary" provides comprehensive information about the IM Nails pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The IM Nails report provides key information and data related to: Extensive coverage of the IM Nails under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories,...